847872-10-0

Basic information

• Product Name: Phenol, 4-amino-5-chloro-2-fluoro-
• Synonyms: Phenol, 4-amino-5-chloro-2-fluoro-;4-Amino-5-chloro-2-fluoro-phenol
• CAS NO: 847872-10-0
• Molecular Formula: C6H5ClFNO
• Molecular Weight: 161.56
• Mol File: 847872-10-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: Phenol, 4-amino-5-chloro-2-fluoro-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 4-amino-5-chloro-2-fluoro-(847872-10-0)
• EPA Substance Registry System: Phenol, 4-amino-5-chloro-2-fluoro-(847872-10-0)

Safety Data

• Hazardous Substances Data: 847872-10-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Phenol, 4-amino-5-chloro-2-fluorois used as an intermediate in the synthesis of pharmaceuticals. Its unique structure allows it to be a versatile building block for the development of new drugs.
Used in Pesticide Industry:
Phenol, 4-amino-5-chloro-2-fluorois also used as a precursor in the manufacture of pesticides. Its ability to inhibit the growth of microorganisms makes it a valuable component in creating effective pest control products.
Used in Dye Manufacturing:
Phenol, 4-amino-5-chloro-2-fluorois utilized as a starting material in the production of dyes. Its aromatic nature and functional groups contribute to the color and properties of the resulting dyes.
Used in Antiseptics and Disinfectants:
Due to its antimicrobial and antifungal properties, Phenol, 4-amino-5-chloro-2-fluorois used in the formulation of antiseptics and disinfectants. It helps to prevent infections and maintain cleanliness in various settings.
Used in Organic Chemistry:
Phenol, 4-amino-5-chloro-2-fluoroplays a significant role in various chemical reactions in the field of organic chemistry. Its presence in different chemical processes highlights its importance in the chemical industry.

Upstream product

• 771-76-6 2-chloro-4,5-difluoronitrobenzene 
• 696-02-6 4-chloro-1,2-difluorobenzene 

Relevant articles and documents

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein NA (I) and pharmaceutically acceptable salts thereof.5 Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein formula (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS

The invention provides novel imidazopyrazine derivatives having general formula (I), wherein R1 to R11 are as described herein, and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.

NOVEL IMIDAZOPYRAZINE DERIVATIVES

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R14 are as described herein (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE

The present invention provides novel substituted pyrazolone compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE

The present invention provides novel substituted pyrazolone compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

SUBSTITUTED QUINOLINE COMPOUNDS AND METHODS OF USE

The present invention provides novel substituted quinoline compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.